Road to First-in-Human Trials for Biologics

Large molecule biologics often have unique characteristics that may require specialized procedures. Understanding and navigating these pathways while ensuring compliance with stringent and ever-changing regulations can be challenging. How do you adapt your trials strategy to current market conditions ?

More information and registration you can find here.